Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
14th October 2020 | Bryan Giraudo | 3,000 | Open or private purchase | $10.01 | $30,036.00 |
11th August 2020 | Chaitan Phd Khosla | 2,499 | Open or private sale | $17.19 | $42,952.06 |
11th August 2020 | Chaitan Phd Khosla | 2,499 | Exercise of derivative | $1.89 | $4,723.11 |
23rd June 2020 | Bryan Giraudo | 2,000 | Open or private purchase | $12.96 | $25,922.40 |
29th April 2020 | Dinesh V Ph D Patel | 2,000 | Bona fide gift | $0.00 | |
20th March 2020 | Dinesh V Ph D Patel | 10,000 | Exercise of derivative | $1.89 | $18,900.00 |
12th March 2020 | Dinesh V Ph D Patel | 18,344 | Exercise of derivative | $1.16 | $21,279.04 |
12th March 2020 | Harold E Selick | 12,000 | Open or private purchase | $6.70 | $80,400.00 |
14th February 2020 | Bryan Giraudo | 46,500 | Grant/award etc. | $0.00 | |
3rd December 2019 | Dinesh V Ph D Patel | 10,000 | Open or private purchase | $5.55 | $55,500.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm's initial lead product candidates are being developed for moderate-to-severe ulcerative colitis and Crohn's disease.
1st December 2020
6th November 2020
6th November 2020
6th November 2020